Drug therapy for the prevention and treatment of bronchopulmonary dysplasia

Frontiers in Pharmacology
Anjali Iyengar, Jonathan M Davis

Abstract

As more infants are surviving at younger gestational ages, bronchopulmonary dysplasia (BPD) remains as a frequent neonatal complication occurring after preterm birth. The multifactorial nature of the disease process makes BPD a challenging condition to treat. While multiple pharmacologic therapies have been investigated over the past two decades, there have been limited advances in the field. Often multiple therapies are used concurrently without clear evidence of efficacy, with potential for significant side effects from drug-drug interactions. Systematic literature review. Although there is physiologic rationale for the use of many of these therapies, none of them has single-handedly altered the incidence, severity, or progression of BPD. Future research should focus on developing clinically significant end-points (short and long term respiratory assessments), investigating biomarkers that accurately predict risk and progression of disease, and creating appropriate stratification models of BPD severity. Applying a multi-modal approach to the study of new and existing drugs should be the most effective way of establishing the optimal prevention and treatment regimens for BPD.

Associated Clinical Trials

References

Nov 1, 1990·The American Review of Respiratory Disease·K L BrundageJ T Fisher
Feb 16, 1967·The New England Journal of Medicine·W H NorthwayD Y Porter
Feb 14, 1998·European Journal of Pediatrics·K De BoeckH Devlieger
Dec 10, 1999·Pediatric Research·A J Jobe
May 5, 2000·The Cochrane Database of Systematic Reviews·L P Brion, R A Primhak
Jul 6, 2000·Journal of Perinatology : Official Journal of the California Perinatal Association·J M DavisN Kassem
Feb 24, 2001·Annals of the New York Academy of Sciences·F BroeckaertA Bernard
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·A H Jobe, E Bancalari
Sep 15, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·A N MacRitchieR D Bland
Mar 1, 2002·The Cochrane Database of Systematic Reviews·L P Brion, R A Primhak
Mar 4, 2003·Pediatrics·Jonathan M DavisUNKNOWN North American Recombinant Human CuZnSOD Study Group
Apr 5, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Sam AfsharPhilip W Shaul
Oct 24, 2003·The Journal of Surgical Research·Christopher MichettiPaul Wolf
Feb 18, 2004·Pediatric Pulmonology·Beverley RobinAmy Goldstein-Filbrun
Oct 22, 2004·Pediatric Research·Jeffrey D MerrillPhilip L Ballard
Feb 17, 2005·Pediatrics·Namasivayam AmbalavananUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Jun 11, 2005·American Journal of Respiratory and Critical Care Medicine·Faruqa LadhaBernard Thébaud
Jul 8, 2005·The New England Journal of Medicine·Krisa P Van MeursUNKNOWN Preemie Inhaled Nitric Oxide Study
Dec 3, 2005·Pediatrics·Richard A EhrenkranzUNKNOWN National Institutes of Child Health and Human Development Neonatal Research Network
Jan 31, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Vivek BalasubramaniamSteven H Abman
May 19, 2006·The New England Journal of Medicine·Barbara SchmidtUNKNOWN Caffeine for Apnea of Prematurity Trial Group
Jun 17, 2006·Pediatric Pulmonology·T Pantalitschka, C F Poets
Jul 28, 2006·The New England Journal of Medicine·Roberta A BallardUNKNOWN NO CLD Study Group
Jul 28, 2006·The New England Journal of Medicine·John P KinsellaSteven H Abman
Aug 23, 2006·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Ryszard LauterbachKrzysztof Rytlewski
Dec 7, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Thomas L MillerMarla R Wolfson
Mar 27, 2007·The Journal of Pediatrics·Kristi L Watterberg
Sep 11, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jen-Ruey TangSteven H Abman
Nov 9, 2007·The New England Journal of Medicine·Barbara SchmidtUNKNOWN Caffeine for Apnea of Prematurity Trial Group
Nov 9, 2007·The New England Journal of Medicine·Eugenio Baraldi, Marco Filippone
May 23, 2008·European Journal of Pediatrics·Anne Greenough
Jun 4, 2008·European Journal of Pediatrics·Alexandra J J SchramaFrans J Walther

❮ Previous
Next ❯

Citations

Sep 12, 2015·Jornal de pediatria·Jose Dirceu Ribeiro, Gilberto Bueno Fischer
Nov 23, 2018·Pediatric Research·María Álvarez-FuenteMaria Jesús Del Cerro
Sep 1, 2017·Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses·Alexandra Kesler JohnsonAmy J Jnah
Aug 4, 2016·Molecular Pharmacology·Thomas M RaffayBenjamin Gaston
Jul 2, 2017·Clinical Science·Emanuele AmataLoredana Salerno
Aug 3, 2016·American Journal of Respiratory Cell and Molecular Biology·Simon G RoyceClaudia A Nold-Petry
Jan 11, 2020·Frontiers in Pediatrics·Meredith E MowitzSujata P Sarda
Jan 23, 2020·Pediatric Research·Jonathan MichaudNathalie Auger
Sep 7, 2020·American Journal of Perinatology·Keren Armoni DomanyMoran Lavie
Nov 26, 2018·The Journal of Pediatrics·David LeyUNKNOWN study team
Nov 28, 2017·The Journal of Pediatrics·Robin SteinhornUNKNOWN International Neonatal Consortium
Oct 8, 2020·Neonatology·Elizabeth J ThompsonChristoph P Hornik

❮ Previous
Next ❯

Methods Mentioned

BETA
PMA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinics in Perinatology
Andrea Trembath, Matthew M Laughon
Expert Review of Respiratory Medicine
Lannae Strueby, Bernard Thébaud
Journal of Perinatology : Official Journal of the California Perinatal Association
N V RajuG G Konduri
© 2021 Meta ULC. All rights reserved